Maximus (NYSE:MMS) Issues FY 2025 Earnings Guidance

Maximus (NYSE:MMS - Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided EPS guidance of 6.30-6.600 for the period, compared to the consensus EPS estimate of 6.100. The company issued revenue guidance of $5.3 billion-$5.4 billion, compared to the consensus revenue estimate of $5.3 billion.

Maximus Stock Down 0.6 %

NYSE MMS traded down $0.43 during mid-day trading on Friday, reaching $75.31. The stock had a trading volume of 598,966 shares, compared to its average volume of 561,537. The company has a fifty day moving average price of $68.07 and a 200 day moving average price of $73.06. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. Maximus has a 1 year low of $63.77 and a 1 year high of $93.97. The stock has a market cap of $4.26 billion, a PE ratio of 16.20 and a beta of 0.61.

Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.37 by $0.64. Maximus had a return on equity of 21.95% and a net margin of 5.28%. The firm had revenue of $1.36 billion for the quarter, compared to the consensus estimate of $1.29 billion. During the same period in the prior year, the company posted $1.57 earnings per share. The company's quarterly revenue was up 1.0% on a year-over-year basis. On average, research analysts expect that Maximus will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be given a dividend of $0.30 per share. The ex-dividend date is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.59%. Maximus's dividend payout ratio (DPR) is 25.81%.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised Maximus from a "hold" rating to a "buy" rating in a report on Wednesday.

Insider Transactions at Maximus

In other news, insider Ilene R. Baylinson sold 14,500 shares of the firm's stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the sale, the insider now directly owns 2,512 shares in the company, valued at $171,167.68. This trade represents a 85.23 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Jan Madsen sold 2,439 shares of the stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the sale, the director now owns 18,097 shares of the company's stock, valued at $1,225,347.87. The trade was a 11.88 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company's stock.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.